{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:20:34Z","timestamp":1776277234582,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571422"],"award-info":[{"award-number":["32571422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118354","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:50:10Z","timestamp":1763272210000},"page":"118354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["Discovery of novel pyrimidine-based KRAS-G12C inhibitors with potent anti-NSCLC activity via virtual screening and structure optimization"],"prefix":"10.1016","volume":"302","author":[{"given":"Jian-Tao","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Juan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Long","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Ya","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Wu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118354_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/cancers14051321","article-title":"Direct targeting KRAS mutation in non-small cell lung cancer: focus on resistance","volume":"14","author":"Reita","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118354_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2021.05.026","article-title":"A retrospective observational study of the natural history of advanced non-small-cell lung cancer in patients with KRAS-G12C mutated or wild-type disease","volume":"159","author":"Spira","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejmech.2025.118354_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2021.02.002","article-title":"KRAS-G12C-Mutant non-small cell lung cancer: biology, developmental therapeutics, and molecular testing","volume":"23","author":"Veluswamy","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ejmech.2025.118354_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13036-024-00450-3","article-title":"Integrating allele-specific PCR with CRISPR-Cas13a for sensitive KRAS mutation detection in pancreatic cancer","volume":"18","author":"Amintas","year":"2024","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.ejmech.2025.118354_bib5","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1021\/acs.jmedchem.2c01244","article-title":"Targeting extracellular signal-regulated protein kinase 1\/2 (ERK1\/2) in cancer: an update on pharmacological small-molecule inhibitors","volume":"65","author":"Fu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155093","article-title":"Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K\/AKT signaling pathway","volume":"121","author":"Hou","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118354_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175752","article-title":"Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment","volume":"952","author":"Wang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118354_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"KRAS-G12C inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118354_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cell.2018.01.006","article-title":"Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor","volume":"172","author":"Janes","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118354_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105652","article-title":"Discovery of ARS-1620 analogs as KRAS-G12C inhibitors with high in vivo antitumor activity","volume":"121","author":"Zhao","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104825","article-title":"Discovery of novel quinazoline-based covalent inhibitors of KRAS-G12C with various cysteine-targeting warheads as potential anticancer agents","volume":"110","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a covalent inhibitor of KRAS-G12C (AMG510) for the treatment of solid tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS-G12C inhibitor AMG510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118354_bib14","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/acs.jmedchem.9b02052","article-title":"Identification of the clinical development candidate MRTX849, a covalent KRAS-G12C inhibitor for the treatment of cancer","volume":"63","author":"Fell","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib15","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.21.02752","article-title":"First-in-Human phase I\/IB dose-finding study of adagrasib (MRTX849) in patients with advanced KRASG12C solid tumors (KRYSTAL-1)","volume":"40","author":"Ou","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118354_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.adg9652","article-title":"Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS","volume":"381","author":"Schulze","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118354_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2023.11.011","article-title":"A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS","volume":"31","author":"Duan","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2025.118354_bib18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-024-02120-6","article-title":"Fulzerasib: first approval","volume":"84","author":"Lamb","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.118354_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41392-025-02315-7","article-title":"Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-na\u00efve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies","volume":"10","author":"Yuan","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118354_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2213-2600(24)00110-3","article-title":"Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial","volume":"12","author":"Li","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2025.118354_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41591-024-03401-z","article-title":"Glecirasib in KRAS-G12C-mutated nonsmall-cell lung cancer: a phase 2b trial","volume":"31","author":"Shi","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118354_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41392-025-02274-z","article-title":"Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation","volume":"10","author":"Ruan","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118354_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117878","article-title":"Recent advance of KRAS-G12C inhibitors for cancer therapy","volume":"296","author":"Li","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.915512","article-title":"Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C","volume":"12","author":"Zhuang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118354_bib25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jtho.2021.04.015","article-title":"KRAS secondary mutations that confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and adagrasib, and overcoming strategies: insights from in vitro experiments","volume":"16","author":"Koga","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejmech.2025.118354_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108050","article-title":"Resistance looms for KRAS G12C inhibitors and rational tackling strategies","volume":"229","author":"Zhang","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118354_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","article-title":"KRAS inhibitors: resistance drivers and combinatorial strategies","volume":"11","author":"Isermann","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejmech.2025.118354_bib28","doi-asserted-by":"crossref","first-page":"15102","DOI":"10.1021\/acs.jmedchem.2c00947","article-title":"Discovery, optimization, and evaluation of selective CDK4\/6 inhibitors for the treatment of breast cancer","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107467","article-title":"Discovery of novel coumarin-based KRAS-G12C inhibitors from virtual screening and rational structural optimization","volume":"148","author":"Shi","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot4493","article-title":"Acridine Orange\/Ethidium bromide (AO\/EB) staining to detect apoptosis","volume":"2006","author":"Kasibhatla","year":"2006","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejmech.2025.118354_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymeth.2013.01.008","article-title":"Measuring apoptosis by microscopy and flow cytometry","volume":"61","author":"Henry","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.ejmech.2025.118354_bib32","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1039\/C9AY01836K","article-title":"A mitochondria\u2013nucleolus migration fluorescent probe for monitoring of mitochondrial membrane potential and identification of cell apoptosis","volume":"11","author":"Li","year":"2019","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ejmech.2025.118354_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.envpol.2019.05.026","article-title":"Deoxynivalenol induced apoptosis and inflammation of IPEC-J2 cells by promoting ROS production","volume":"251","author":"Kang","year":"2019","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.ejmech.2025.118354_bib34","article-title":"Mitochondrial swelling and generation of reactive oxygen species induced by photoirradiation are heterogeneously distributed","volume":"1011","author":"Ti","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118354_bib35","doi-asserted-by":"crossref","first-page":"325a","DOI":"10.1016\/j.bpj.2016.11.1759","article-title":"Dysregulation of mitochondrial permeability transition pore (MPTP) is associated with enhanced ROS production in skeletal muscle of an ALS mouse model","volume":"112","author":"Xiao","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118354_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-020-01202-9","article-title":"Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118354_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105865","article-title":"Synthesis and in vitro\/in vivo anticancer evaluation of pentacyclic triterpenoid derivatives linked with l-phenylalanine or l-proline","volume":"126","author":"Yin","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117551","article-title":"Structural simplification of quaternary benzophenanthridine alkaloids generating a candidate for the treatment of non-small cell lung cancer","volume":"290","author":"Xu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118354_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106412","article-title":"1H-Indazoles derivatives targeting PI3K\/AKT\/mTOR pathway: synthesis, anti-tumor effect and molecular mechanism","volume":"133","author":"Wang","year":"2023","journal-title":"Bioorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:27:50Z","timestamp":1773804470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0223523425011195"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118354","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel pyrimidine-based KRAS-G12C inhibitors with potent anti-NSCLC activity via virtual screening and structure optimization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118354"}}